Betting big on M&As
Dr Reddy's Laboratories' June 11 announcement that it had entered into an agreement with Teva and Allergan to buy eight…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Editor’s note
Moving up the green ladder
As the Modi Government launches its second anniversary celebration on May 26, the BJP will be organising 200 odd events over a…
Embracing quality as an opportunity
Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the brand…
To switch or not to switch …
A notice dated March 30 from the Drug Controller General
(India) asking for ‘science-based suggestions/ comments’ on the pros and…
Quality consciousness: A pre-requisite to progress
Manufacturing quality has now become probably the single most important concern in the boardrooms of pharmaceutical companies in…
Weeding out the bad FDCs
The fixed dose combination (FDC) issue has been a contentious one for years and on March 10 came back to haunt pharma companies in…
Once again, nothing much for pharma
In his third budget, Finance Minister Arun Jaitley has taken one more shot at a balancing act between maintaining fiscal…
Public health: In need of Nari Shakti
As we mark yet another Women’s Day this March, here are some sobering words from Sanghita Bhattacharyya, Senior Public Health…
Revival mantras for MSMEs
Precious things come in small packages (think diamonds)
Acche Din Kab Aayenge?
All eyes are once again on India's Finance Minister Arun Jaitley as he prepares to present the Modi Government's second full…
Online pharmacies both game changers and troublemakers
I’d hazard a guess that there is hardly anyone who is not a user of e-commerce platforms to ease the daily grind
WL dims Sun’s shine … a bit
A new year brings with it new hope but all indications are that 2016 is going to be a mixed bag for the pharmaceutical industry
Of laws and flaws
Could New Jersey Superior Court's decision this October be a wake up call for Indian companies with global ambitions
Sifting the trends into 2016
If the latest edition of the Antal Global Snapshot (AGS) on annual global hiring and firing trends is any indicator, hiring in…
Will new IP policy ensure Sabka Vikas?
In our last issue, we highlighted Swati Spentose’s quiet rise to become a Rs 40-crore speciality API manufacturer
Finding the hidden gems
Vishal Jajodia could sign up as a poster boy for Prime Minister Narendra Modi's Make In India campaign
Balancing the scales
Besides the balanced reasoning within the Delhi HC judgement, it is the SC's intervention which could see this case go down as a…
Mainstreaming AYUSH
The last month saw a major milestone in the patent versus patient debate
Playing for high stakes
According to the latest data from the India Brand Equity Foundation (IBEF), the Indian domestic pharma market ended FY15 with a…
Mylan’s One Quality Standard a long way off
Some industry observers are surprised that ‘significant violations’ of this nature have not warranted an import alert or ban